Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31065464 | 0.82 | MAPT (0.57) | CES2CES1KEAP1MAPTAHR | |
| SCHEMBL1537396 | 0.82 | MAPT (0.57) | CES2CES1KEAP1MAPTAHR | |
| Tetrahydrofuran SCHEMBL27873622 | 0.82 | HTT (0.42) | CES2CES1KEAP1MAPTAHR | |
| SCHEMBL22485690 | 0.81 | CES2 (0.45) | CES2CES1KEAP1MAPTAHR | |
| SCHEMBL24017067 | 0.77 | ALOX5 (0.42) | CES2CES1KEAP1MAPTAHR | |
| SCHEMBL11329381 | 0.77 | — | — | |
| SCHEMBL79717 | 0.77 | — | — | |
| SCHEMBL1384962 | 0.77 | TSHR (0.57) | CES2CES1KEAP1MAPTTSHR | |
| SCHEMBL14564985 | 0.77 | — | — | |
| SCHEMBL1691719 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388836-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL TERTHIOPHENE COMPOUND OR THIOPHENE OLIGOMER COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-8053147-B2 | Advantageous recording media for holographic applications | BAYER MATERIALSCIENCE AG (DE) | 2011-11-08 | — | — | US | claimed |
| EP-2137732-A1 | ADVANTAGEOUS RECORDING MEDIA FOR HOLOGRAPHIC APPLICATIONS | Bayer MaterialScience AG (DE) | 2009-12-30 | — | — | EP | claimed |
| US-20090185470-A1 | ADVANTAGEOUS RECORDING MEDIA FOR HOLOGRAPHIC APPLICATIONS | BAYER MATERIALSCIENCE AG (DE) | 2009-07-23 | — | — | US | claimed |
| WO-2008125229-A1 | ADVANTAGEOUS RECORDING MEDIA FOR HOLOGRAPHIC APPLICATIONS | BAYER MATERIALSCIENCE AG (DE) | 2008-10-23 | — | — | WO | claimed |
| US-11605813-B2 | Silicon-based energy storage devices with functional terthiophene compound or thiophene oligomer compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-03-14 | — | — | US | disclosed |
| US-20200388836-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL TERTHIOPHENE COMPOUND OR THIOPHENE OLIGOMER COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| US-20200388836-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL TERTHIOPHENE COMPOUND OR THIOPHENE OLIGOMER COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| CN-107189197-B | Comprehensive conveying pipe for high-strength insulating flame-retardant pipeline gallery | 上海中塑管业有限公司 | 2020-05-12 | — | — | CN | disclosed |
| US-7368516-B2 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2008-05-06 | — | — | US | disclosed |
| US-20050187419-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2005-08-25 | — | — | US | disclosed |
| US-6900152-B2 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20020035029-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | TOSOH CORPORATION (JP) | 2002-03-21 | — | — | US | disclosed |
| US-6337297-B1 | CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP | TOSOH CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187419-A1 | Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst | ACMSD, TAF9, ETV6 | CES2 366/4885CES1 1157/4885KEAP1 1893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.